NCT07237607 Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
| NCT ID | NCT07237607 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Milton S. Hershey Medical Center |
| Condition | Eating Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-03-23 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-03-23 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to develop and refine an artificial intelligence (AI)-powered Exposure Therapy for Eating Disorders chatbot web-app that effectively engages adolescents and young adults and decreases anxiety about weight gain. Participants will use the web-app as a supplemental therapeutic tool during their first six weeks of treatment in a Partial Hospitalization Program. Participants will complete assessments every two weeks, including: (1) semi-structured interviews about their experience with the chatbot web-app; (2) implementation outcome measures (e.g., feasibility, usability, acceptability); and (3) anxiety about weight gain.
Eligibility Criteria
Inclusion Criteria: * Age is between or equal to 12-26 years * Admitted to the Penn State Health Eating Disorder Partial Hospital Program (PHP) or Intensive Outpatient Program (IOP) * Have a personal smartphone * Have a diagnosis of anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), or other specified feeding or eating disorder (OSFED) * Be English speaking Exclusion Criteria: * Diagnosis of avoidant/restrictive food intake disorder (ARFID) * Have acute suicidality * Diagnosis of an intellectual disability
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07237607 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 26 Years, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07237607 currently recruiting?
Yes, NCT07237607 is actively recruiting participants. Contact the research team at jessayli@pennstatehealth.psu.edu for enrollment information.
Where is the NCT07237607 trial being conducted?
This trial is being conducted at Hershey, United States.
Who is sponsoring the NCT07237607 clinical trial?
NCT07237607 is sponsored by Milton S. Hershey Medical Center. The trial plans to enroll 20 participants.